From the Department of Neurology, Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh School of Medicine, PA (P.S., K.Z., S.H.H., X.Z., X.T., H.P., R.A.S., J.C., K.-J.Y.).
Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Healthcare System, PA (J.C., K.-J.Y.).
Circ Res. 2020 Apr 10;126(8):1040-1057. doi: 10.1161/CIRCRESAHA.119.315886. Epub 2020 Mar 5.
Angiogenesis promotes neurological recovery after stroke and is associated with longer survival of stroke patients. Cerebral angiogenesis is tightly controlled by certain microRNAs (miRs), such as the miR-15a/16-1 cluster, among others. However, the function of the miR-15a/16-1 cluster in endothelium on postischemic cerebral angiogenesis is not known.
To investigate the functional significance and molecular mechanism of endothelial miR-15a/16-1 cluster on angiogenesis in the ischemic brain.
Endothelial cell-selective miR-15a/16-1 conditional knockout (EC-miR-15a/16-1 cKO) mice and wild-type littermate controls were subjected to 1 hour middle cerebral artery occlusion followed by 28-day reperfusion. Deletion of miR-15a/16-1 cluster in endothelium attenuates post-stroke brain infarction and atrophy and improves the long-term sensorimotor and cognitive recovery against ischemic stroke. Endothelium-targeted deletion of the miR-15a/16-1 cluster also enhances post-stroke angiogenesis by promoting vascular remodeling and stimulating the generation of newly formed functional vessels, and increases the ipsilateral cerebral blood flow. Endothelial cell-selective deletion of the miR-15a/16-1 cluster up-regulated the protein expression of pro-angiogenic factors VEGFA (vascular endothelial growth factor), FGF2 (fibroblast growth factor 2), and their receptors VEGFR2 (vascular endothelial growth factor receptor 2) and FGFR1 (fibroblast growth factor receptor 1) after ischemic stroke. Consistently, lentiviral knockdown of the miR-15a/16-1 cluster in primary mouse or human brain microvascular endothelial cell cultures enhanced in vitro angiogenesis and up-regulated pro-angiogenic proteins expression after oxygen-glucose deprivation, whereas lentiviral overexpression of the miR-15a/16-1 cluster suppressed in vitro angiogenesis and down-regulated pro-angiogenic proteins expression. Mechanistically, miR-15a/16-1 translationally represses pro-angiogenic factors VEGFA, FGF2, and their receptors VEGFR2 and FGFR1, respectively, by directly binding to the complementary sequences within 3'-untranslated regions of those messenger RNAs.
Endothelial miR-15a/16-1 cluster is a negative regulator for postischemic cerebral angiogenesis and long-term neurological recovery. Inhibition of miR-15a/16-1 function in cerebrovascular endothelium may be a legitimate therapeutic approach for stroke recovery.
血管生成促进中风后的神经恢复,与中风患者的生存时间延长有关。脑内血管生成受某些 microRNAs(miRs)的严格控制,例如 miR-15a/16-1 簇等。然而,内皮细胞中 miR-15a/16-1 簇在缺血性脑内血管生成中的功能尚不清楚。
研究内皮细胞 miR-15a/16-1 簇在缺血性脑内血管生成中的功能意义和分子机制。
对内皮细胞选择性 miR-15a/16-1 条件性敲除(EC-miR-15a/16-1 cKO)小鼠和野生型同窝对照小鼠进行 1 小时大脑中动脉闭塞,然后进行 28 天再灌注。内皮细胞中 miR-15a/16-1 簇的缺失可减轻中风后脑梗死和萎缩,并改善对缺血性中风的长期感觉运动和认知恢复。血管生成后,内皮细胞靶向 miR-15a/16-1 簇的缺失也可通过促进血管重塑和刺激新形成的功能性血管生成来增强血管生成,并增加对侧大脑血流。内皮细胞选择性缺失 miR-15a/16-1 簇可上调中风后促血管生成因子 VEGFA(血管内皮生长因子)、FGF2(成纤维细胞生长因子 2)及其受体 VEGFR2(血管内皮生长因子受体 2)和 FGFR1(成纤维细胞生长因子受体 1)的蛋白表达。同样,在原代小鼠或人脑微血管内皮细胞培养物中,慢病毒下调 miR-15a/16-1 簇可增强体外血管生成,并上调氧葡萄糖剥夺后促血管生成蛋白的表达,而慢病毒过表达 miR-15a/16-1 簇可抑制体外血管生成,并下调促血管生成蛋白的表达。在机制上,miR-15a/16-1 通过直接结合到那些信使 RNA 的 3'非翻译区的互补序列来翻译抑制促血管生成因子 VEGFA、FGF2 及其受体 VEGFR2 和 FGFR1。
内皮细胞 miR-15a/16-1 簇是缺血后大脑血管生成和长期神经恢复的负调节剂。抑制脑血管内皮细胞中 miR-15a/16-1 的功能可能是中风恢复的一种合理治疗方法。